These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 29323154)

  • 21. Sanguinarine inhibits pancreatic cancer stem cell characteristics by inducing oxidative stress and suppressing sonic hedgehog-Gli-Nanog pathway.
    Ma Y; Yu W; Shrivastava A; Alemi F; Lankachandra K; Srivastava RK; Shankar S
    Carcinogenesis; 2017 Oct; 38(10):1047-1056. PubMed ID: 28968696
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Targeting colorectal cancer cell metabolism through development of cisplatin and metformin nano-cubosomes.
    Saber MM; Al-Mahallawi AM; Nassar NN; Stork B; Shouman SA
    BMC Cancer; 2018 Aug; 18(1):822. PubMed ID: 30111296
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effectiveness of an anti-human IL-6 receptor monoclonal antibody combined with chemotherapy to target colon cancer stem-like cells.
    Ying J; Tsujii M; Kondo J; Hayashi Y; Kato M; Akasaka T; Inoue T; Shiraishi E; Inoue T; Hiyama S; Tsujii Y; Maekawa A; Kawai S; Fujinaga T; Araki M; Shinzaki S; Watabe K; Nishida T; Iijima H; Takehara T
    Int J Oncol; 2015 Apr; 46(4):1551-9. PubMed ID: 25625841
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metformin increases sensitivity of osteosarcoma stem cells to cisplatin by inhibiting expression of PKM2.
    Shang D; Wu J; Guo L; Xu Y; Liu L; Lu J
    Int J Oncol; 2017 May; 50(5):1848-1856. PubMed ID: 28393220
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metformin enhances cisplatin cytotoxicity by suppressing signal transducer and activator of transcription-3 activity independently of the liver kinase B1-AMP-activated protein kinase pathway.
    Lin CC; Yeh HH; Huang WL; Yan JJ; Lai WW; Su WP; Chen HH; Su WC
    Am J Respir Cell Mol Biol; 2013 Aug; 49(2):241-50. PubMed ID: 23526220
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Altered glutamine metabolism in platinum resistant ovarian cancer.
    Hudson CD; Savadelis A; Nagaraj AB; Joseph P; Avril S; DiFeo A; Avril N
    Oncotarget; 2016 Jul; 7(27):41637-41649. PubMed ID: 27191653
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metformin and prostate cancer stem cells: a novel therapeutic target.
    Mayer MJ; Klotz LH; Venkateswaran V
    Prostate Cancer Prostatic Dis; 2015 Dec; 18(4):303-9. PubMed ID: 26215782
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Metformin targets gastric cancer stem cells.
    Courtois S; Durán RV; Giraud J; Sifré E; Izotte J; Mégraud F; Lehours P; Varon C; Bessède E
    Eur J Cancer; 2017 Oct; 84():193-201. PubMed ID: 28822889
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MRI assessment of glutamine uptake correlates with the distribution of glutamine transporters and cancer stem cell markers.
    Seo Y; Kang J; Kim TI; Joo CG
    Sci Rep; 2022 Apr; 12(1):5511. PubMed ID: 35365739
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Doxycycline Induces Apoptosis and Inhibits Proliferation and Invasion of Human Cervical Carcinoma Stem Cells.
    Yang B; Lu Y; Zhang A; Zhou A; Zhang L; Zhang L; Gao L; Zang Y; Tang X; Sun L
    PLoS One; 2015; 10(6):e0129138. PubMed ID: 26111245
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cancer Stem-like Properties in Colorectal Cancer Cells with Low Proteasome Activity.
    Munakata K; Uemura M; Tanaka S; Kawai K; Kitahara T; Miyo M; Kano Y; Nishikawa S; Fukusumi T; Takahashi Y; Hata T; Nishimura J; Takemasa I; Mizushima T; Ikenaga M; Kato T; Murata K; Carethers JM; Yamamoto H; Doki Y; Mori M
    Clin Cancer Res; 2016 Nov; 22(21):5277-5286. PubMed ID: 27166395
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Construction and application of a lung cancer stem cell model: antitumor drug screening and molecular mechanism of the inhibitory effects of sanguinarine.
    Yang J; Fang Z; Wu J; Yin X; Fang Y; Zhao F; Zhu S; Li Y
    Tumour Biol; 2016 Oct; 37(10):13871-13883. PubMed ID: 27485114
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Is Metformin a Therapeutic Paradigm for Colorectal Cancer: Insight into the Molecular Pathway?
    Thent ZC; Zaidun NH; Azmi MF; Senin MI; Haslan H; Salehuddin R
    Curr Drug Targets; 2017; 18(6):734-750. PubMed ID: 27919208
    [TBL] [Abstract][Full Text] [Related]  

  • 34. FOXM1-Induced PRX3 Regulates Stemness and Survival of Colon Cancer Cells via Maintenance of Mitochondrial Function.
    Song IS; Jeong YJ; Jeong SH; Heo HJ; Kim HK; Bae KB; Park YH; Kim SU; Kim JM; Kim N; Ko KS; Rhee BD; Han J
    Gastroenterology; 2015 Oct; 149(4):1006-16.e9. PubMed ID: 26091938
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sensitization to oxaliplatin in HCT116 and HT29 cell lines by metformin and ribavirin and differences in response to mitochondrial glutaminase inhibition.
    Richard SM; Martinez Marignac VL
    J Cancer Res Ther; 2015; 11(2):336-40. PubMed ID: 26148596
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ursolic acid inhibits proliferation and reverses drug resistance of ovarian cancer stem cells by downregulating ABCG2 through suppressing the expression of hypoxia-inducible factor-1α in vitro.
    Wang WJ; Sui H; Qi C; Li Q; Zhang J; Wu SF; Mei MZ; Lu YY; Wan YT; Chang H; Guo PT
    Oncol Rep; 2016 Jul; 36(1):428-40. PubMed ID: 27221674
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Targeting the metabolic plasticity of multiple myeloma with FDA-approved ritonavir and metformin.
    Dalva-Aydemir S; Bajpai R; Martinez M; Adekola KU; Kandela I; Wei C; Singhal S; Koblinski JE; Raje NS; Rosen ST; Shanmugam M
    Clin Cancer Res; 2015 Mar; 21(5):1161-71. PubMed ID: 25542900
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ABCG2 is required for self-renewal and chemoresistance of CD133-positive human colorectal cancer cells.
    Ma L; Liu T; Jin Y; Wei J; Yang Y; Zhang H
    Tumour Biol; 2016 Sep; 37(9):12889-12896. PubMed ID: 27449042
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Caffeic Acid Targets AMPK Signaling and Regulates Tricarboxylic Acid Cycle Anaplerosis while Metformin Downregulates HIF-1α-Induced Glycolytic Enzymes in Human Cervical Squamous Cell Carcinoma Lines.
    Tyszka-Czochara M; Bukowska-Strakova K; Kocemba-Pilarczyk KA; Majka M
    Nutrients; 2018 Jun; 10(7):. PubMed ID: 29958416
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sirolimus and Metformin Synergistically Inhibits Colon Cancer In Vitro and In Vivo.
    Mussin N; Oh SC; Lee KW; Park MY; Seo S; Yi NJ; Kim H; Yoon KC; Ahn SW; Kim HS; Hong SK; Oh DK; Suh KS
    J Korean Med Sci; 2017 Sep; 32(9):1385-1395. PubMed ID: 28776332
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.